Simon is an experienced corporate transactional lawyer specialising in equity capital markets. He acts for issuers, principally in connection with IPOs and secondary capital raisings on the Main Market and AIM, and has advised nominated advisers and brokers in connection with various AIM transactions. Simon regularly advises start-ups and growth companies on alternative forms of raising finance, including advising a leading fintech company in connection with its crowdfunding campaigns and several privately held companies in connection with bond offers. He also advises on public and private M&A transactions (both domestic and cross-border).

In addition, Simon advises public and private companies in connection with debt finance facilities and applicable security documentation.

As well as representing issuers coming to the market for the first time, Simon advises issuers and their boards in relation to the ongoing requirements of being a publicly quoted company, including the application of the Listing Rules, The Takeover Code and the Market Abuse Regulation. He is also the Company Secretary of an AIM-quoted company.

  • As always, Simon provided his meticulous discerning approach in supporting Wild Nutrition through this recent investment process with Piper. He has been an invaluable partner since Wild’s inception.

    Charlie Norton, Director and Co-Founder
    Wild Nutrition

  • We are delighted to announce the completion of the debt restructuring documentation. Extension of the debt’s maturity will enable us to continue with our growth strategy, as we seek to take full advantage of the positive conditions in the global iodine market, and build our position as one of the industry’s best operators. We are very grateful to Simon for his solid counsel and his unwavering dedication in assisting us over the years.

    Tom Becker, CEO and President